Chengdu huasun technology group Inc. , LTD.

SZSE:000790 주식 보고서

시가총액: CN¥2.7b

Chengdu huasun technology group 과거 수익 실적

과거 기준 확인 1/6

Chengdu huasun technology group's earnings have been declining at an average annual rate of -16.3%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 7.1% per year. Chengdu huasun technology group's return on equity is 2%, and it has net margins of 1.2%.

주요 정보

-16.3%

수익 성장률

-17.0%

EPS 성장률

Pharmaceuticals 산업 성장10.9%
매출 성장률7.1%
자기자본 수익률2.0%
순이익1.2%
최근 수익 업데이트30 Sep 2024

최근 과거 실적 업데이트

Some Investors May Be Willing To Look Past Chengdu huasun technology group's (SZSE:000790) Soft Earnings

May 06
Some Investors May Be Willing To Look Past Chengdu huasun technology group's (SZSE:000790) Soft Earnings

Recent updates

What Chengdu huasun technology group Inc. , LTD.'s (SZSE:000790) 30% Share Price Gain Is Not Telling You

Oct 28
What Chengdu huasun technology group Inc. , LTD.'s (SZSE:000790) 30% Share Price Gain Is Not Telling You

Some Investors May Be Willing To Look Past Chengdu huasun technology group's (SZSE:000790) Soft Earnings

May 06
Some Investors May Be Willing To Look Past Chengdu huasun technology group's (SZSE:000790) Soft Earnings

수익 및 비용 분석

Chengdu huasun technology group 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

SZSE:000790 수익, 비용 및 수입 (CNY Millions )
날짜수익수익G+A 비용R&D 비용
30 Sep 249941238830
30 Jun 249782237234
31 Mar 249622734032
31 Dec 231,0032831632
30 Sep 239393627920
30 Jun 239493927618
31 Mar 238863626421
01 Jan 238734127025
30 Sep 221,0094727022
30 Jun 221,0245027022
31 Mar 221,0135326023
01 Jan 229555628218
30 Sep 217784228615
30 Jun 217853830322
31 Mar 217794331819
31 Dec 207593832020
30 Sep 207553931927
30 Jun 207154733518
31 Mar 207185634723
31 Dec 197456235923
30 Sep 197276836625
30 Jun 197125937235
31 Mar 196593836027
31 Dec 186333134327
30 Sep 1861624031825
30 Jun 1859417030322
31 Mar 1862217328321
31 Dec 1759117225517
30 Sep 176121025510
30 Jun 17595772320
31 Mar 17592802440
31 Dec 16575822470
30 Sep 16511412460
30 Jun 16459-252590
31 Mar 16451-362550
31 Dec 15463-372500
30 Sep 15499-92560
30 Jun 15500572070
31 Mar 15525642060
31 Dec 14528662020
30 Sep 14576431840
30 Jun 14642441900
31 Mar 14616481610
31 Dec 13658501640

양질의 수익: 000790 has high quality earnings.

이익 마진 증가: 000790's current net profit margins (1.2%) are lower than last year (3.9%).


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: 000790's earnings have declined by 16.3% per year over the past 5 years.

성장 가속화: 000790's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

수익 대 산업: 000790 had negative earnings growth (-66.2%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-1.2%).


자기자본 수익률

높은 ROE: 000790's Return on Equity (2%) is considered low.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기